Case Evaluation
Over $150 Million Collected for Plantiffs in 2011

Blog

Date posted: 9/27/2012

September 24, 2012 – With experts linking the blood thinner Pradaxa to severe internal bleeding and hundreds filing lawsuits for injury or death, a federal judge recently scheduled an initial hearing and indicated when trials would begin.

If you have been affected by internal bleeding or the loss of a loved one from Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible. You may be entitled to substantial compensation.

Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. Although only on the market since October, 2010, the drug has earned over $1 billion for manufacturer Boehringer Ingelheim and has been used in over 70 countries.

Date posted: 9/5/2012

September 5, 2012 – As the maker of Pradaxa issued a report last month that use of the drug had reached record levels, a federal judge ruled that they will have to face the potential of thousands of injury and death lawsuits over internal bleeding side effects.

If you have been affected by internal bleeding or the loss of a loved one from Pradaxa, it is important to speak with a lawyer about your legal options as soon as possible.

Pradaxa is a popular blood thinner prescribed to prevent strokes and blood clots in those with atrial fibrillation. On August 27, 2012, manufacturer Boehringer Ingelheim issued an announcement that the drug has now been prescribed for one million patient-years of combined time, and has been used in over 70 countries worldwide.

Date posted: 8/22/2012

August 21, 2012 - The popular blood thinner Pradaxa has been associated with severe and sometimes fatal internal bleeding. Now, those patients affected will have the right to seek recovery after a federal judge ruled lawsuits against the manufacturer can proceed.

Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. The manufacturer, German drug company Boehringer Ingelheim, has already earned over $1 billion selling it in the few short years it has been on the market.

Date posted: 8/8/2012

August 8, 2012 – Two weeks after hearing arguments from several lawyers involved in the current Pradaxa bleeding lawsuits, the Judicial Panel on Multidistrict Litigation today issued an order consolidating the outstanding cases to the MDL court in the Southern District of Illinois.

The move could help victims of Pradaxa injury as it will expedite litigation and offer a forum for the sharing of valuable medical evidence. In addition, the judge selected to preside over the cases is highly qualified in similar matters.

Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular blood thinning drug prescribed to prevent strokes and blood clots in patients with atrial fibrillation.

Date posted: 7/31/2012

July 31, 2012 - Patients who suffered internal bleeding after taking the drug Pradaxa should soon know where and how injury claims filed by hundreds with similar injuries will be handled now that a federal panel has heard arguments from both sides.

Anyone who suffered internal bleeding or lost a loved one due to taking Pradaxa should speak with a lawyer about their legal rights as soon as possible.

Pradaxa is an anticoagulant medication that has been prescribed to hundreds of thousands of patients with atrial fibrillation to prevent blood clots and stroke.

Date posted: 7/18/2012

July 18, 2012 – Next week, a federal panel will decide the fate of lawsuits filed by victims who took Pradaxa and suffered internal bleeding injuries. The decision will affect whether the cases will be consolidated under one court, and where that court will be located.

Any patient who suffered internal bleeding or lost a loved one after taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is an anticoagulant prescribed to those afflicted with atrial fibrillation in order to prevent strokes and blood clots. It has only been on the market since October of 2010, however, for the year ending in February, 2012, the drug sold over $1 billion with prescriptions to hundreds of thousands of patients.

Date posted: 7/3/2012

July 4, 2012 – Recent reports indicate that Boehringer Ingelheim, the company who manufactures the popular anticoagulant Pradaxa, is now working to develop an antidote that will stop internal bleeding issues which have plagued the drug so far.

The move follows warnings by the FDA, European Medicines Agency and Institute for Safe Medication Practices that Pradaxa could cause irreversible internal bleeding attacks, as well as the filing of multiple lawsuits over serious injury and death.

Date posted: 6/7/2012

June 8, 2012 - Patients who have taken or may be prescribed the drug Pradaxa are being warned of a new report which shows the FDA received more complaints of serious injury or patient death in Pradaxa users than with any other drug last year.

If you or a loved one suffered from internal bleeding after taking Pradaxa, it is important to speak with a lawyer about your legal rights as soon as possible.

Pradaxa is prescribed to patients suffering from atrial fibrillation in order to prevent strokes. The manufacturer, Boehringer Ingelheim, recently boasted in it’s annual report that the drug reached blockbuster status of selling $1 billion.

Date posted: 4/18/2012

In the midst of an FDA warning over the safety of Pradaxa, several lawsuits alleging patient death and growing public concern over uncontrollable internal bleeding, the maker of the drug has released a new study which unsurprisingly shows the drug is safer than alternatives.

On December 7, 2011, the FDA announced it would launch an investigation into the safety of Pradaxa after receiving hundreds of reports of patient death. Experts say nearly 1,000 people in all have suffered injury or death after taking the drug.

Date posted: 4/18/2012

Just a year and a half after Pradaxa was released as a safe and effective anticoagulant for those dealing with atrial fibrillation, the drug faces FDA safety warnings, hundreds of reports of fatal internal bleeding, and now the first Pradaxa lawsuits by families dealing with loss.

Bloomberg reported recently that the first lawsuits over Pradaxa internal bleeding were filed last month in Louisiana, Tennessee and Kentucky.

« prev 1 2 next »
Facebook Twitter Youtube